6 September 2022

COVID-19 booster vaccine offered to optical staff

The optical sector has confirmed that frontline healthcare workers throughout the UK will be offered the COVID-19 booster vaccination this autumn. This includes optical staff working in primary eye care settings.

At this stage, please note the following information available for the four UK nations following the booster programme update by the Joint Committee on Vaccination and Immunisation (JCVI):

  • England: The booster rollout starts week beginning 5 September when highest risk groups – e.g. people who are housebound – will be prioritised. The National Booking Service will open and take bookings from 12 September onwards for people aged 75 and older (NHS England). At this stage we expect frontline healthcare workers to be called after this initial cohort but at this stage please wait for further updates from the NHS. Around 3,100 sites are planned to be made available including GP practices and pharmacies. The program will be expanded by October to include 26 million people, with all over-50s invited to participate. 
  • Northern Ireland: The booster rollout starts on 19 September using GPs, pharmacists and Trusts. Pharmacies will be able to offer frontline optical teams the jab once the rollout starts. (HSCB).
  • Scotland: The booster rollout is scheduled to start in early September, with healthcare workers expected to be prioritised early on. Exact details are pending (Scottish Government).
  • Wales: The booster rollout starts this week, starting with highest risk groups. Details on when healthcare workers will be able to access a jab are to be confirmed (Welsh Government).

This article was correct at time of publication. 

Related further reading

How should you market your business while avoiding outlandish claims and falling foul of the Advertising Standards Authority? Juliette Astrup reports.

Which elements are key to the process of shared decision-making between clinician and patient? Georgina Wintersgill reports.

Léa Surugue looks at the costly and debilitating effects of migraine, and how better classification can protect patients’ health.